Viatris Inc recalls Cardura XL (doxazosin) extended release tablets 4 mg
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Failed Impurities/Degradation Specifications: Out of specification results observed for the impurity compound B during stability testing.
- Products
-
- Cardura XL (doxazosin) extended release tablets 4 mg
- Company
- Viatris Inc
- Where it was sold
-
USA nationwide.
Nationwide
- Units affected
- 6,605/30 count bottles
- About this recall
- Cardura XL (doxazosin) extended release tablets 4 mg, 30 -count bottle, Rx only, Distributed by Viatris Specialty LLC, Morgantown, WV 26505, NDC 58151-078-93